{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:38:34Z","timestamp":1790635114711,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.3233\/jad-180240","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T15:06:49Z","timestamp":1530025609000},"page":"889-897","source":"Crossref","is-referenced-by-count":11,"title":["Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for\u00a0Cognitive Disorders"],"prefix":"10.1177","volume":"64","author":[{"given":"Claire","family":"Paquet","sequence":"first","affiliation":[{"name":"Cognitive Neurology Center, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"},{"name":"Inserm U942, Universite Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bouaziz-Amar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[{"name":"Cognitive Neurology Center, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"},{"name":"Inserm U942, Universite Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Volpe-Gillot","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leopold Bellan Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Saint Camille Hospital, Bry-sur-Marnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Mahieux","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Sainte-Perrine Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Dekimeche","sequence":"additional","affiliation":[{"name":"Departmentof Geriatrics, Les Gonesses Hospital, Gonesses, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Defontaines","sequence":"additional","affiliation":[{"name":"Alois Network, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Chabriat","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Belin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Avicennes Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Texeira","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Goutagny","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beaujon Hospital, AP-HP, Clichy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Questel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Azuar","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Sellier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Laplanche","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Hugon","sequence":"additional","affiliation":[{"name":"Cognitive Neurology Center, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"},{"name":"Inserm U942, Universite Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[{"name":"Cognitive Neurology Center, Lariboisi\u00e8re \u2013 Fernand Widal Hospital, AP-HP, Paris, France"},{"name":"Inserm U942, Universite Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"e62","key":"10.3233\/JAD-180240_ref1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: A systematic review and metaanalysis.","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute onAging-Alzheimer\u2019s Association guidelines for theneuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JAD-170793","article-title":"Reproducibility of Alzheimer\u2019s disease cerebrospinal fluid-biomarkermeasurements under clinical routine conditions.","volume":"62","author":"Vogelgsang","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-170128","article-title":"Concordance between cerebrospinal fluid biomarkers with Alzheimer\u2019s disease pathology between three independent assay platforms.","volume":"61","author":"Doecke","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3233\/JAD-170324","article-title":"Cost-utility of using Alzheimer\u2019sdisease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia.","volume":"60","author":"Handels","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"e191","key":"10.3233\/JAD-180240_ref6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2014.06.006","article-title":"The use of biomarkers for the etiologicdiagnosis of MCI in Europe: An EADC survey.","volume":"11","author":"Bocchetta","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000449410","article-title":"Are CSF biomarkers useful as prognostic indicators indiagnostically unresolved cognitively impaired patients in a normalclinical setting.","volume":"6","author":"Schjonning","year":"2016","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.3233\/JAD-180240_ref8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-beta1-42 inpatients with dementia.","volume":"138","author":"Skillback","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-180240_ref9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendationsfrom the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining thepreclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer\u2019s Association criteria for preclinical Alzheimer disease.","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180240_ref12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: Alongitudinal study.","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180240_ref14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline inclinically normal individuals.","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-180240_ref15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints.","volume":"81","author":"van","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: A longitudinal cohort study.","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180240_ref17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-170502","article-title":"Current approaches and clinician attitudes to the use of cerebrospinal fluid biomarkers in diagnostic evaluation of dementiain Europe.","volume":"60","author":"Miller","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-161252","article-title":"Cerebrospinal fluid biomarkers and clinical progression in patients with subjective cognitive declineand mild cognitive impairment.","volume":"58","author":"Wolfsgruber","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3233\/JAD-160975","article-title":"The clinical use of cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: The Italian Selfie.","volume":"55","author":"Sancesario","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3233\/JAD-170511","article-title":"Alzheimer\u2019s disease biomarkers and future decline incognitive normal older adults.","volume":"60","author":"Dumurgier","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00415-013-7160-3","article-title":"Impact of cerebro-spinal fluid biomarkers of Alzheimer\u2019s disease in clinical practice: A multicentric study.","volume":"261","author":"Mouton-Liger","year":"2014","journal-title":"J Neurol"},{"key":"10.3233\/JAD-180240_ref23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-132672","article-title":"Who needs cerebrospinal biomarkers? A national survey in clinical practice.","volume":"40","author":"Troussiere","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-015-0114-5","article-title":"Cerebrospinal fluid amyloid-beta 42\/40 ratio in clinical setting of memory centers: A multicentric study.","volume":"7","author":"Dumurgier","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180240_ref25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2012.06.006","article-title":"Intersite variability of CSF Alzheimer\u2019s disease biomarkers in clinical setting.","volume":"9","author":"Dumurgier","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer\u2019s Association quality control program.","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180240_ref27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/alzrt267","article-title":"A diagnostic scale for Alzheimer\u2019s disease based on cerebrospinal fluid biomarker profiles.","volume":"6","author":"Lehmann","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180240_ref28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00406-015-0628-7","article-title":"Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer\u2019s disease.","volume":"266","author":"Alexopoulos","year":"2016","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-180240_ref29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.55.9.809","article-title":"The relationships between age, sex, and the incidence of dementia and Alzheimer disease: Ameta-analysis.","volume":"55","author":"Gao","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-180240_ref30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref31","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00415-010-5630-4","article-title":"Association between male gender andcortical Lewy body pathology in large autopsy series.","volume":"257","author":"Nelson","year":"2010","journal-title":"J Neurol"},{"key":"10.3233\/JAD-180240_ref32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","article-title":"Alzheimer\u2019s disease andvascular dementia in developing countries: Prevalence, management, and risk factors.","volume":"7","author":"Kalaria","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180240_ref33","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/brain\/awv199","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarker in cognitively normal subjects.","volume":"138","author":"Toledo","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-180240_ref34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0b013e3182872830","article-title":"Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.","volume":"80","author":"Prestia","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-180240_ref36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/brain\/awv029","article-title":"Prevalence and prognosis of Alzheimer\u2019s disease at the mildcognitive impairment stage.","volume":"138","author":"Vos","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-180240_ref37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-170098","article-title":"The effects ofcortical hypometabolism and hippocampal atrophy on clinical trajectories in mild cognitive impairment with suspectednon-Alzheimer\u2019s pathology: A brief report.","volume":"60","author":"Chung","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180240_ref38","unstructured":"Hanon O , Vidal JS , Lehmann S , Bombois S , Allinquant B , Treluyer JM , Gele P , Delmaire C , Blanc F , Mangin JF , Buee L , Touchon J , Hugon J , Vellas B , Galbrun E , Benetos A , Berrut G , Paillaud E , Wallon D , Castelnovo G , Volpe-Gillot L , Paccalin M , Robert PH , Godefroy O , Dantoine T , Camus V , Belmin J , Vandel P , Novella JL , Duron E , Rigaud AS , Schraen-Maschke S , Gabelle A (2018) BALTAZAR study group Plasma amyloid levels within the Alzheimer\u2019s process and correlations with central biomarkers Alzheimers Dement. 10.1016\/j.jalz.2018.01.004."},{"issue":"192","key":"10.3233\/JAD-180240_ref39","first-page":"194re","article-title":"Changes in amyloid-beta and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.","volume":"5","author":"Maia","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-180240_ref40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2017.04.030","article-title":"Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models.","volume":"354","author":"Clement","year":"2017","journal-title":"Neuroscience"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:25Z","timestamp":1777370845000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":40,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180240","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]}}}